Thanks Tim & other posters. Quite appreciate your thoughts & findings.
Does anyone have visibility over the revenue potential assuming the FDA approvals come through ?
NEU was listed in AFR 2014 as one of the best 23 bio stocks. In 2015 again NEU is picked as a top bio stock of the year. So lots of people thinking huge company maker potential in short term and biggest possible re-rating in SP.
As some posters have compared AJX & NEU, would like to know if NEU is the next AJX ?
If the answer is yes then probably whoever missed the AJX train so far can have a wonderful second chance
Good luck everyone..interesting days ahead.
FDA decision within 1-50 days, page-15
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |